Item 5.02Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers

On March 17, 2021, Tadataka Yamada, M.D. notified the board of directors (the "Board") of Agilent Technologies, Inc. (the "Company") of his intention to retire as a member of the Company's Board, effective the same day. Dr. Yamada is a member of the Compensation Committee and Nominating/Corporate Governance Committee of the Board. Dr. Yamada has served as a member of the Board since 2011. Dr. Yamada's retirement is not the result of any disagreement with the Company regarding its operations, policies or practices.

In connection with Dr. Yamada's retirement, the size of the Board has been reduced from eleven to ten directors, effective as of March 17, 2021.

Item 5.07Submission of Matters to a Vote of Security Holders

The Annual Meeting of Stockholders of the Company was held on March 17, 2021 (the "Annual Meeting"). A total of 271,409,984 shares of Common Stock, representing approximately 88.87% of the shares outstanding, were represented at the Annual Meeting. The voting results for each item of business properly presented at the Annual Meeting, as certified by the Company's independent inspector of elections, are set forth below:


Proposal No. 1 The election of four (4) directors for a term of three years. The

               individuals listed below received the affirmative vote of a
               majority of the votes cast by the shares present in person or
               represented by proxy and entitled to vote at the Annual Meeting,
               and were each elected to serve a three-year term.




          Name               For      Against   Abstain Broker Non-Vote
Mala Anand               245,239,700 5,141,831  316,340   20,712,760
Koh Boon Hwee            202,729,446 47,110,105 858,320   20,712,760

Michael R. McMullen 248,591,433 1,784,764 321,674 20,712,760 Daniel K. Podolsky, M.D. 247,860,506 2,508,190 329,176 20,712,760

Directors Hans E. Bishop, Paul N. Clark, Heidi Kunz, Sue H. Rataj, George A. Scangos, Ph.D. and Dow R. Wilson continued in office following the Annual Meeting.

Proposal No. 2 The non-binding advisory vote to approve the compensation of the


               Company's named executive officers was approved as set forth
               below.




    For      Against    Abstain  Broker Non-Vote
227,177,051 20,394,969 3,125,850   20,712,760

Proposal No. 3 The proposal to ratify the Audit and Finance Committee's


               appointment of PricewaterhouseCoopers LLP as the Company's
               independent registered public accounting firm for the 2021 fiscal
               year was approved as set forth below.




    For      Against   Abstain Broker Non-Vote(1)
256,916,210 14,111,810 382,610         0

(1) Pursuant to the rules of the New York Stock Exchange, this proposal

constituted a routine matter. Therefore, brokers were permitted to vote

without receipt of instructions from beneficial owners.

© Edgar Online, source Glimpses